기업명 | 주식 심볼 | 시장 | 주식 타입 |
---|---|---|---|
Gyre Therapeutics Inc | GYRE | 나스닥 | 보통주 |
개장가 | 저가 | 고가 | 종가 | 전일 종가 |
---|---|---|---|---|
15.76 | 15.48 | 15.95 | 15.63 | 15.77 |
최근 뉴스
일자 | 시간 | 출처 | 제목 |
---|---|---|---|
14/05/2024 | 05:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/05/2024 | 05:10 | GLOBE | Gyre Therapeutics Reports First Quarter 2024 Financial.. |
10/05/2024 | 05:05 | EDGAR2 | Form 8-K - Current report |
08/05/2024 | 21:00 | EDGAR2 | Form 8-K - Current report |
26/03/2024 | 19:00 | GLOBE | Gyre Therapeutics Reports Full Year 2023 Financial Results.. |
21/03/2024 | 20:00 | GLOBE | Gyre Therapeutics Expands Board of Directors with.. |
15/12/2023 | 23:04 | PRNUS | Totus Medicines Announces Appointment of Nassim Usman,.. |
13/11/2023 | 21:00 | GLOBE | Gyre Therapeutics Presents Poster at the American.. |
03/11/2023 | 06:00 | EDGAR2 | Form 8-K - Current report |
02/11/2023 | 06:18 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
02/11/2023 | 05:58 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |